IntroMedic Co., Ltd. (KOSDAQ:150840)

Market Cap	6.45B
Revenue (ttm)	10.06B
Net Income (ttm)	-1.38B
Shares Out	43.00M
EPS (ttm)	-32.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,315,070
Average Volume	10,180,020
Open	215.00
Previous Close	170.00
Day's Range	135.00 - 300.00
52-Week Range	57.00 - 300.00
Beta	-0.66
RSI	n/a
Earnings Date	n/a

About IntroMedic

IntroMedic Co., Ltd. engages in the manufacture and sale of manufacture and sale of medical and information communication devices in South Korea and internationally. It offers MiroCam, a capsule endoscope system; E.G. Scan, a ductile video esophagoscope; and EndoClot, an absorbent hemostasis equipment for internal body. The company was formerly known as Metis Medical Systems Co., Ltd. and changed its name to IntroMedic Co., Ltd. in March 2006. IntroMedic Co., Ltd. was founded in 2004 and is headquartered in Seoul, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 59
• Stock Exchange: KOSDAQ
• Ticker Symbol: 150840

Financial Performance

In 2024, IntroMedic's revenue was 10.38 billion, an increase of 4.09% compared to the previous year's 9.98 billion. Losses were -6.95 billion, 1.94% more than in 2023.